Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML; Multi Center Therapy Concept

NCT00606723 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT00606723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00606723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML; Multi Center Therapy Concept
Lead sponsor
Hannover Medical School
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2010
Completion date
February 24, 2021
Enrollment
154 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml)